Coronavirus Vaccine: Oxford vaccine is considered good for India due to these reasons, know what it is


Worldwide, the number of people infected with the coronavirus has now crossed six crores seven lakhs while more than 14 lakh people have died so far. In such a situation, a vaccine is considered the only way to get out of the coronavirus epidemic. Many vaccines are in operation worldwide. Many companies have even announced highly successful trials of their Kovid vaccine, ranging from Oxford to Pfizer and BioNotech and Moderna. However, of these, the best Oxford vaccine is considered to be India. Let's know what it is in this vaccine that it is being described as the most suitable for India.

According to reports, the Oxford-AstraZeneca vaccine is effective on people of all ages, from children to the elderly. Initial results have also indicated that the risk of an untreated corona infection by applying this vaccine may be greatly reduced.

The Oxford-AstraZeneca vaccine is easier to maintain than other companies. According to reports, the Oxford vaccine can be stored at a normal temperature, while Moderna and Pfizer require temperatures ranging from minus 20 to minus 80 degrees.

The price of the Oxford-AstraZeneca vaccine will also be lower than other vaccines. While one of its doses will cost around Rs 500, Pfizer's one dose will cost $ 19.50, which is around Rs 1450, while the Moderna vaccine will be priced between $ 25 to $ 37, which is around Rs 1850-2700.

The Serum Institute of India is conducting trials of the Oxford-AstraZeneca vaccine in India. He will launch it under the name 'Kovishield'. Adar Poonawala, Head of Serum Institute, says that this vaccine will come first in the Indian market, only then other vaccines are likely to come.